These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23174406)

  • 21. Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case-control studies.
    Zhu B; Wu X; Zhi X; Liu L; Zheng Q; Sun G
    PLoS One; 2014; 9(7):e102443. PubMed ID: 25047451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of methylene tetrahydrofolate reductase C677T genotype with type 2 diabetes mellitus patients with and without renal complications.
    Movva S; Alluri RV; Venkatasubramanian S; Vedicherla B; Vattam KK; Ahuja YR; Hasan Q
    Genet Test Mol Biomarkers; 2011 Apr; 15(4):257-61. PubMed ID: 21186995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.
    Zhang Y; Chen GQ; Ji Y; Huang B; Shen WS; Deng LC; Xi L; Cao XM
    Mol Biol Rep; 2012 May; 39(5):6203-11. PubMed ID: 22215214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis.
    Zintzaras E; Uhlig K; Koukoulis GN; Papathanasiou AA; Stefanidis I
    J Hum Genet; 2007; 52(11):881-890. PubMed ID: 17805475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.
    Sheng X; Zhang Y; Zhao E; Lu S; Zheng X; Ge H; Lu W
    Mol Biol Rep; 2012 Oct; 39(10):9669-79. PubMed ID: 22729883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Sun H; Han B; Zhai H; Cheng X; Ma K
    Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the methylenetetrahydrofolate reductase gene C677T polymorphism with the risk of male infertility: a meta-analysis.
    Zhu X; Liu Z; Zhang M; Gong R; Xu Y; Wang B
    Ren Fail; 2016; 38(2):185-93. PubMed ID: 26584688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
    Ma C; Liu Y; Zhang W; Liu P
    Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene and susceptibility to depression in Asian population: a systematic meta-analysis.
    Rai V
    Cell Mol Biol (Noisy-le-grand); 2014; 60(3):29-36. PubMed ID: 26177556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.
    Fu LY; Dai LM; Li XG; Zhang K; Bai Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():56-61. PubMed ID: 24192663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the MTHFR C677T polymorphism with primary brain tumor risk.
    Xu C; Yuan L; Tian H; Cao H; Chen S
    Tumour Biol; 2013 Dec; 34(6):3457-64. PubMed ID: 23846816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy.
    Rai V; Kumar P
    Neurol Sci; 2018 Dec; 39(12):2033-2041. PubMed ID: 30267335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM) susceptibility.
    Meng Y; Liu X; Ma K; Zhang L; Lu M; Zhao M; Guan MX; Qin G
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1020. PubMed ID: 31663297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
    Yi K; Yang L; Lan Z; Xi M
    Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese].
    Sun J; Xu Y; Zhu Y
    Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):529-32. PubMed ID: 11718053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of MTHFR C677T polymorphism and type 2 diabetes mellitus in MENA region.
    El Alami H; Ouenzar F; Errafii K; Alidrissi N; Belyamani L; Ghazal H; Wakrim L; Abidi O; Naamane A; Daoud R; Khlil N; Hamdi S
    Diabetes Metab Syndr; 2024 Feb; 18(2):102965. PubMed ID: 38373383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran.
    Rahimi Z; Hasanvand A; Felehgari V
    DNA Cell Biol; 2012 Apr; 31(4):553-9. PubMed ID: 21942443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR gene) with ischemic stroke: a meta-analysis.
    Kumar A; Kumar P; Prasad M; Sagar R; Yadav AK; Pandit AK; Jali VP; Pathak A
    Neurol Res; 2015 Jul; 37(7):568-77. PubMed ID: 25591425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative assessment of the association between MTHFR C677T polymorphism and hemorrhagic stroke risk.
    Zhao X; Jiang H
    Mol Biol Rep; 2013 Jan; 40(1):573-8. PubMed ID: 23184002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MTHFR C677T polymorphism contributes to the risk for gastric cancer.
    Yan S; Xu D; Wang P; Wang P; Liu C; Hua C; Jiang T; Zhang B; Li Z; Lu L; Liu X; Wang B; Zhang D; Zhang R; He S; Sun B; Wang X
    Tumour Biol; 2014 Mar; 35(3):2123-32. PubMed ID: 24122207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.